查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1418519

单细胞基因组定序市场报告：2030 年趋势、预测与竞争分析

Single-Cell Genome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

单细胞基因组定序趋势与预测

预计 2024 年至 2030 年，全球单细胞基因组定序市场将以 14.6% 的复合年增长率成长。该市场的主要驱动因素包括癌症、糖尿病和关节炎等慢性疾病的盛行率不断上升、先进技术和现代合作研究以及老年人口的增加。全球单细胞基因组定序市场的未来看起来充满希望，循环细胞、细胞分化/重编程、基因组变异和亚群表征市场存在机会。

单细胞基因组定序市场洞察

Lucintel 预计，由于采用尖端设备和解决方案，设备在预测期内仍将是最大的细分市场。

由于循环性肿瘤细胞的使用不断增加，循环细胞仍然是市场中最大的部分。

由于癌症和其他慢性病盛行率不断上升，北美在预测期内可能仍然是最大的地区。

常问问题

Q1.市场成长预测如何？

A1. 2024年至2030年，全球单细胞基因组定序市场预计将以14.6%的复合年增长率成长。

Q2.影响市场成长的主要驱动因素有哪些？

A2. 这个市场的主要驱动因素是癌症、糖尿病和关节炎等慢性疾病的盛行率不断上升、先进技术和现代协作研究以及老年人口数量的增加。

Q3.市场的主要细分市场有哪些？

A3. 单细胞基因组定序市场的未来看起来充满希望，在循环细胞、细胞分化/重编程、基因组变异和亚群表征市场方面存在着机会。

Q4.市场上主要企业有哪些？

A4.主要的单细胞基因组定序公司如下。

  • Bio-Rad Laboratories
  • 10X Genomics
  • Novogene
  • Fluidigm
  • F. Hoffmann-La-Roche
  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Thermo Fisher Scientific
  • Qiagen

Q5.未来最大的细分市场是什么？

A5.Lucintel 预计，由于采用尖端设备和解决方案，设备在预测期内仍将是其最大的细分市场。

Q6. 未来五年预计哪个地区将成为最大的市场？

A6. 由于癌症和其他慢性病盛行率不断上升，预计北美在预测期内仍将是最大的地区。

Q7. 可以客製化报告吗？

A7. 是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球单细胞基因组定序市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球单细胞基因组定序市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球单细胞基因组定序市场
    • 装置
    • 试剂
  • 按工作流程分類的全球单细胞基因组定序市场
    • 基因组分析
    • 单细胞分离
    • 样品製备
  • 全球单细胞基因组定序市场（按应用）
    • 循环细胞
    • 细胞分化/重编程
    • 基因组变异
    • 亚群的表征
    • 其他的
  • 按最终用途分類的全球单细胞基因组定序市场
    • 学术研究所
    • 生物技术和生物製药公司
    • 诊所
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球单细胞基因组定序市场（按地区）
  • 北美单细胞基因组定序市场
  • 欧洲单细胞基因组定序市场
  • 亚太地区单细胞基因体定序市场
  • 其他地区的单细胞基因组定序市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球单细胞基因组定序市场成长机会
    • 按工作流程分類的全球单细胞基因组定序市场成长机会
    • 全球单细胞基因组定序市场成长机会（依应用）
    • 全球单细胞基因组定序市场成长机会（依最终用途）
    • 全球单细胞基因组定序市场成长机会（按地区）
  • 全球单细胞基因组定序市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球单细胞基因组定序市场产能扩张
    • 全球单细胞基因组定序市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • Bio-Rad Laboratories
  • 10x Genomics
  • Novogene
  • Fluidigm
  • F. Hoffmann-La-Roche
  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Thermo Fisher Scientific
  • QIAGEN
简介目录

Single-Cell Genome Sequencing Trends and Forecast

The future of the global single-cell genome sequencing market looks promising with opportunities in the circulating cells, cell differentiation/reprogramming, genomic variation, and subpopulation characterization markets. The global single-cell genome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are chronic illnesses including cancer, diabetes, and arthritis are becoming more common, advanced technology and latest collaborations, and growing number of elderly people.

A more than 150-page report is developed to help in your business decisions.

Single-Cell Genome Sequencing by Segment

The study includes a forecast for the global single-cell genome sequencing by product type, workflow, application, end use, and region.

Single-Cell Genome Sequencing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Reagents

Single-Cell Genome Sequencing Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

  • Genomic Analysis
  • Single Cell Isolation
  • Sample Preparation

Single-Cell Genome Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Circulating Cells
  • Cell Differentiation/Reprogramming
  • Genomic Variation
  • Subpopulation Characterization
  • Others

Single-Cell Genome Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academic & Research Laboratories
  • Biotechnology & Biopharmaceutical Companies
  • Clinics
  • Others

Single-Cell Genome Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Single-Cell Genome Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies single-cell genome sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the single-cell genome sequencing companies profiled in this report include-

  • Bio-Rad Laboratories
  • 10X Genomics
  • Novogene
  • Fluidigm
  • F. Hoffmann-La-Roche
  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Thermo Fisher Scientific
  • Qiagen

Single-Cell Genome Sequencing Market Insights

Lucintel forecasts that instruments will remain the largest segment over the forecast period due to embracing of cutting-edge instruments and solutions.

Within this market, circulating cells will remain the largest segment due to growing utilization of circulating tumor cells.

North America will remain the largest region over the forecast period due to rising prevalence of cancer and other chronic ailments.

Features of the Global Single-Cell Genome Sequencing Market

Market Size Estimates: Single-cell genome sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Single-cell genome sequencing market size by various segments, such as by product type, workflow, application, end use, and region in terms of value ($B).

Regional Analysis: Single-cell genome sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, workflow, application, end use, and regions for the single-cell genome sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the single-cell genome sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for single-cell genome sequencing market?

Answer: The global single-cell genome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the single-cell genome sequencing market?

Answer: The major drivers for this market are chronic illnesses including cancer, diabetes, and arthritis are becoming more common, advanced technology and latest collaborations, and growing number of elderly people.

Q3. What are the major segments for single-cell genome sequencing market?

Answer: The future of the single-cell genome sequencing market looks promising with opportunities in the circulating cells, cell differentiation/reprogramming, genomic variation, and subpopulation characterization markets.

Q4. Who are the key single-cell genome sequencing market companies?

Answer: Some of the key single-cell genome sequencing companies are as follows.

  • Bio-Rad Laboratories
  • 10X Genomics
  • Novogene
  • Fluidigm
  • F. Hoffmann-La-Roche
  • Illumina
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Thermo Fisher Scientific
  • Qiagen

Q5. Which single-cell genome sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the largest segment over the forecast period due to embracing of cutting-edge instruments and solutions.

Q6. In single-cell genome sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising prevalence of cancer and other chronic ailments.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the single-cell genome sequencing market by product type (instruments and reagents), workflow (genomic analysis, single cell isolation, and sample preparation), application (circulating cells, cell differentiation/reprogramming, genomic variation, subpopulation characterization, and others), end use (academic & research laboratories, biotechnology & biopharmaceutical companies, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Single-Cell Genome Sequencing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Single-Cell Genome Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Single-Cell Genome Sequencing Market by Product Type
    • 3.3.1: Instruments
    • 3.3.2: Reagents
  • 3.4: Global Single-Cell Genome Sequencing Market by Workflow
    • 3.4.1: Genomic Analysis
    • 3.4.2: Single Cell Isolation
    • 3.4.3: Sample Preparation
  • 3.5: Global Single-Cell Genome Sequencing Market by Application
    • 3.5.1: Circulating Cells
    • 3.5.2: Cell Differentiation/Reprogramming
    • 3.5.3: Genomic Variation
    • 3.5.4: Subpopulation Characterization
    • 3.5.5: Others
  • 3.6: Global Single-Cell Genome Sequencing Market by End Use
    • 3.6.1: Academic & Research Laboratories
    • 3.6.2: Biotechnology & Biopharmaceutical Companies
    • 3.6.3: Clinics
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Single-Cell Genome Sequencing Market by Region
  • 4.2: North American Single-Cell Genome Sequencing Market
    • 4.2.2: North American Single-Cell Genome Sequencing Market by Application: Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization, and Others
  • 4.3: European Single-Cell Genome Sequencing Market
    • 4.3.1: European Single-Cell Genome Sequencing Market by Product Type: Instruments and Reagents
    • 4.3.2: European Single-Cell Genome Sequencing Market by Application: Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization, and Others
  • 4.4: APAC Single-Cell Genome Sequencing Market
    • 4.4.1: APAC Single-Cell Genome Sequencing Market by Product Type: Instruments and Reagents
    • 4.4.2: APAC Single-Cell Genome Sequencing Market by Application: Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization, and Others
  • 4.5: ROW Single-Cell Genome Sequencing Market
    • 4.5.1: ROW Single-Cell Genome Sequencing Market by Product Type: Instruments and Reagents
    • 4.5.2: ROW Single-Cell Genome Sequencing Market by Application: Circulating Cells, Cell Differentiation/Reprogramming, Genomic Variation, Subpopulation Characterization, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by Workflow
    • 6.1.3: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by Application
    • 6.1.4: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by End Use
    • 6.1.5: Growth Opportunities for the Global Single-Cell Genome Sequencing Market by Region
  • 6.2: Emerging Trends in the Global Single-Cell Genome Sequencing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Single-Cell Genome Sequencing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Single-Cell Genome Sequencing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bio-Rad Laboratories
  • 7.2: 10x Genomics
  • 7.3: Novogene
  • 7.4: Fluidigm
  • 7.5: F. Hoffmann-La-Roche
  • 7.6: Illumina
  • 7.7: Oxford Nanopore Technologies
  • 7.8: Pacific Biosciences
  • 7.9: Thermo Fisher Scientific
  • 7.10: QIAGEN